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A B S T R A C T
A reliable method for the estimation of seizure frequency and severity is indispensable in assessing the
efﬁcacy of drug treatment in epilepsies. These quantities are usually deduced from subjective patient
reports, which may cause considerable problems due to insufﬁcient or false descriptions of seizures and
their frequency.
We present data from two difﬁcult-to-treat patients with intractable epilepsy. Pat. 1 has had an
unknown number of CP seizures. Here, a prolonged outpatient video-EEG monitoring over 160 h and
137 h (over an interval of three months) was performed with an automated seizure detection method.
Pat. 2 suffered exclusively from nocturnal seizures originating from the frontal lobe. In this case, an
objective quantiﬁcation of the efﬁcacy of drug treatment over a time period of 22weeks was established.
For the reliable quantiﬁcation of seizures, a prolonged outpatient video/video-EEG monitoring was
appended after a short-term inpatient monitoring period.
Patient 1: The seizure detection algorithmwas capable of detecting 10 out of 11 seizures. The number
of false-positive events was<0.03/h. It was clearly demonstrated that the patient showedmore seizures
than originally reported. Patient 2: The add-onmedication of lacosamide led to a signiﬁcant reduction in
seizure frequency and to a marked decrease in the mean duration of seizures. The severity of seizures
was reduced from numerous hypermotoric seizures to few mild, head-turning seizures.
Outpatient monitoring may be helpful to guide treatment for severe epilepsies and offers the
possibility tomore reliably quantify the efﬁcacy of treatment in the long-term, even over severalmonths.
 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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The aim of treating epilepsies is to control seizures without
causing adverse effects to achieve the best possible quality of life
for the patient. Usually, seizure frequency is counted by subjective* Corresponding author at: University Hospital Erlangen, Epilepsy Centre,
Schwabachanlage 6, 91054 Erlangen, Germany. Tel.: +49 09131 8534541;
fax: +49 09131 8536469.
E-mail address: hermann.stefan@uk-erlangen.de (H. Stefan).
1059-1311/$ – see front matter  2010 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2010.10.035patient reports, which may cause considerable problems due to
incorrect descriptions of seizures and their frequency. Respective
controlled trials showed that seizures were only recognised in 39–
49% of patients.1,2 Nocturnal seizures are not recognised by the
patients in up to 80% of cases.3 The aim of this investigation was to
present a more elaborate and objective approach for quantifying
seizure frequency and duration over a time period of several
months, which would not be feasible in an EMU, using ﬁrst a short
inpatient monitoring period followed by prolonged outpatient
video-EEG/video monitoring. For the investigations, two patients
were selected who represented different issues with respect tovier Ltd. All rights reserved.
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seizures the patient suffered at all. In the second patient, the
seizure frequency and severity were measured after an add-on
lacosamide treatment.
2. Method
Pat. 1 (44y, f) has suffered from symptomatic epilepsy since the
age of 33. The patient usually shows hypomotoric CP seizures, but
rarely, SGTC seizures are observed. Before investigation, the
assumed number of CP seizures was approximately 5 per month.
No clear lesion was detected in the MRI, but the suspicion of a
cortical heterotopia was reported.
The simultaneous video-EEG recording started as an inpatient
monitoring period at our epilepsy centre for three days using the
10–20 system and 2 ECG channels (64 channels, sampling rate
256 Hz, Neuroﬁle XP System, ITmed, Usingen). Following this short
inpatient monitoring period, a prolonged outpatient monitoring
period of seven days (with a recording time of approximately
169 h) was employed using the portable Epi-Home system (ITmed,
Usingen) in a nearby hotel. This system included a laptop
computer, a 38-channel EEG-ampliﬁer (sampling rate 256 Hz), a
special camera for audio/video, and an infrared-lamp for video
recording during nights. This setup was installed near the bedside
(see Fig. 1). The scalp electrodes were glued to provide good
recording conditions. During outpatient monitoring, a medical
assistant went to the hotel every day and serviced the electrodes.
The recorded video-EEG data from the previous day were
transferred via an external USB hard drive from the portable
video-EEG system to the main database in the hospital. Here, the
entire set of EEG data (typical 24 h) was ﬁrst analysed ofﬂine using
an automated seizure detection program that was recently
developed at our hospital. This fast and robust program provides
high sensitivity and an acceptably low rate of false-positive events[()TD$FIG]
Fig. 1. Portable digital video-EEG monitoring system for ambulatory use in a domesti
ampliﬁer. (b) Video camera and infrared-lamp near the bedside of the patient.
Table 1
Titration scheme of anticonvulsive drugs during long-term monitoring.
Drug/serum
concentration
Before
LCM
treatment
Week 1 Week 2 Week 3 Week 4
OXC (mg) 900-0-900 900-0-900 900-0-900 900-0-900 900-0-900
PGB (mg) 300-0-300 300-0-300 300-0-300 300-0-300 300-0-300
LCM (mg) 50-0-50 100-0-100 150-0-150 200-0-200
MHD (mg/ml) 21.5 20.4 18.4 20.9
LCM (mg/ml) 0 1.2 1.9 3.0
NT 1 NT 2
OXC=oxcarbazepine, PGB=pregabaline, LCM= lacosamide, MHD=monohydrate derivatfor scalp-EEG recordings. The program is also routinely used
clinically for presurgical evaluation. Details of the algorithm,
which is essentially based on spectral analysis techniques using
special detection montages for two frequency bands, 3–12 Hz and
12–18 Hz, and seizure detection performance can be found in Ref.
[4]. In addition to automated seizure detection, a visual inspection
of the data was made by experts. The duration of the electro-
graphical seizure pattern was determined visually from the EEG
and semi-automatically from the integrated power.4,5 The outpa-
tientmonitoring in the hotel was repeated again after 3months for
approximately 5 days (recording time 137 h) using the same
procedure described above. In total, 297 h of outpatient video-EEG
data were analysed.
The second patient (Pat. 2) suffers from difﬁcult-to-treat
cryptogenic frontal lobe epilepsy exhibiting frequent hypermo-
toric nocturnal seizures, which he usually did not recognise. The
primary goal was to investigate the efﬁcacy of drug treatment over
more than 22 weeks using prolonged outpatient monitoring. The
clinical characteristics of the patient were as follows: male, age 29
years, 105 kg body weight, epilepsy since age 21, normal MRI. A
routine EEG showed alpha activity with intermittent theta activity
and frontal spikes; ictal SPECT showed a hyperperfusion frontal
right lobe. The neurological examination was normal. Seizure
semiology was as follows: turning of the head to the left side,
ﬂexing of the trunk and hypermotoric movement of the extremi-
ties for several minutes occurring during sleep 40–50 times per
night. Because of the excessive hypermotoric movements, injuries
have occurred several times.
Previous treatment consisted of different anticonvulsive drugs,
including valproate (VPA), oxcarbazepine (OXC) and pregabaline
(PGB). The titration scheme of anticonvulsive drugs during long-
term monitoring over a period of 21 weeks is shown in Table 1.
During this period, lacosamide was added while the dosage of OXC
and PGB was kept nearly constant (in week 16, the daily dosage ofc environment. (a) Shows the laptop computer and the LAN-interface of the EEG
Week 9 Week 10 Week 12 Week 14 Week 16 Week 21
900-0-900 900-0-900 900-0-900 900-0-900 900-0-900 900-0-900
300-0-300 300-0-300 300-0-300 300-0-300 225-0-300 225-0-300
200-0-200 200-0-250 200-0-300 200-0-350 200-0-350 200-0-400
19.6
9.7
NT 3 NT 4
e of oxcarbazepine. NT 1–4: neuropsychological testing.
[()TD$FIG]
Fig. 2. Time course of the integrated power (IP) and the seizure detection value (SDV) for the frequency band of 3–12 Hz over 23 h. The seizure detection montage (reference
montage with respect to Fz-Cz-Pz) comprises electrodes from the right and left hemisphere, respectively. The insets show details of IP and SDV around the seizure.
[()TD$FIG]
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Fig. 3. The duration of the electrographical seizures of the outpatient monitoring in
the hotel. Seizures 1–4 (white) occurred during the ﬁrst stay and seizures 5–11
(black) occurred during the second stay. Seizure 10 was not detected by the
automated seizure detection program.
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measurements of serum concentrations of the anticonvulsive
drugs were taken.
The simultaneous video-EEG recording started as an inpatient
monitoring period at our epilepsy centre for two weeks (week 1
and 3) using the extended 10–20 system (29 EEG channels, 2 ECG
channels). Subsequent to the inpatient monitoring period, a
prolonged outpatient home monitoring period was employed
using the portable Epi-Home system mentioned previously. Most
of the home monitoring consisted only of video recording of the
patient’s seizures during the night because no seizure pattern had
been seen in the EEG. The video was examined carefully by the
parents of the patient (the father is a scientist), and all seizures
were well documented with respect to their frequency and
severity. On one weekend (week 21), both video and an EEG were
recorded. The video and the EEG data were again analysed by
experienced epileptologists.
In addition, thorough neuropsychological testing was per-
formed on Pat. 2. These standardised tests included performance
on tests of information-processing speed, verbal and ﬁgural
memory, topologic memory, incidental memory, concentration
and attention.
3. Results
During the short inpatient monitoring period, Pat. 1 showed
neither clinical/subclinical seizures nor pathological activity in the
EEG. In the subsequent outpatient monitoring period in the hotel,
the patient showed four hypomotoric complex partial seizures
during the daytime. These seizures were correctly identiﬁed by the
automated seizure detection program for the frequency band 3–
12 Hz, (in the band 12–18 Hz, only two seizures were found). No
additional seizureswere found by visual inspection. The number of
false-positive events in both frequency bands was <0.02/h
(corresponding to approximately one false detection in 50 h).For illustration, Fig. 2 shows the integrated power (IP) and the
seizure detection value (SDV) for the 3–12 Hz frequency band over
one day. During the second outpatient monitoring period in the
hotel (after 3 months), the patient showed seven seizures
(presumably six clinical and one subclinical, during sleep). At
one session a medical assistant was present while the patient
suffered a complex partial seizure. Due to the testing procedure, it
turned out that the patient did not notice the seizure at all. The
automated seizure detection program correctly found six seizures
in the frequency band 1. One seizure was missed because the
duration of the corresponding EEG activity was too short (duration
7–8 s); this seizurewas identiﬁed by visual inspection. The number
of false-positive events for all data (137 h) was <0.03/h in both
frequency bands.
Fig. 3 summarises the corresponding durations of each seizure
estimated from the EEG activity. On average, the duration of the
[()TD$FIG]
Fig. 4. The time course of the number of nocturnal seizures per week and the mean
duration of seizures in each week. The dosage of LCM is indicated in the upper
margin.
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monitoring period than during the second one.
Next, the results of patient 2 are presented. During inpatient
monitoring, the patient displayed many nocturnal seizures with
strong hypermotoric activity. The corresponding EEG showed only
artefacts due to the patient’s movement. No seizure pattern was
detected in the EEG before and during visible seizures (this was the
reason for not using an automated seizure detection program). The
time course of seizure frequency and themean duration of seizures
during the uptitration of lacosamide is shown in Fig. 4. There was a
signiﬁcant reduction of seizure frequency and duration, dropping
from 133 nocturnal seizures and amean duration of 50 s in the ﬁrst
week to 57 seizures and a mean seizure duration of 14 s in the
ninth week. In this treatment phase, lacosamide was added to
oxcarbazepine and pregabaline, using up to 400 mg in the ninth
week. During the following weeks (10th–22nd), the dosage of
lacosamide was increased to 600 mg per day. This led to a further
decrease in seizure frequency (e.g. 19 seizures in 22nd week),
whereas the mean duration of seizures slightly increased.
Interestingly, a decrease in the severity of the seizures, from
severe hypermotoric seizures to motor and slight, head-turning
seizures, was also observed. The serum concentration for
lacosamide at the end of the observation period (600 mg LCM)
was 9.7 mg/ml. No side effects of medication were reported by the
patient. Repeated ECG measurements were normal.
Neuropsychological examination over the course of four tests at
different times (Table 1) showed a slight improvement in
incidental and topologic memory performance. Selective attention
remained above average, whereas concentration was below
average in all tests. Verbal and ﬁgural memory were slightly
below average in all tests and did not show any signiﬁcant changes.
4. Discussion
Concerning the actual seizure frequency of Pat. 1, the prolonged
outpatient video-EEGmonitoring in the hotel at two different time
intervals clearly demonstrated that the patient actually suffered
more seizures than counted by herself or her relatives. Further-
more, the electroclinical seizure duration varied between both
monitoring periods. Of course, it was impossible to estimate the
clinical duration of the seizures because, without one exception, no
adequate testing could be performed. Therefore, only the durationof the seizure activity estimated from the EEGmight provide some
hints about the actual duration of seizures.
It is noteworthy that the seizure detection algorithm using
standardised parameters was capable of correctly detecting 10 of
11 seizures, whereas the number of false-positives was quite low
(approximately 0.03/h over 297 h). The important point is that the
automated seizure detection, including the fast review capability
of the compressed display of the integrated power, provided a
signiﬁcant reduction in the time needed for analysing the huge
amount of video-EEG data during outpatient monitoring where no
observer was present, as in EMUs.
In Pat. 2, with difﬁcult-to-treat epilepsy, the efﬁcacy of add-on
treatment by means of lacosamide could be objectively docu-
mented in a long-term follow up by in- and outpatient monitoring
over a time period of ﬁvemonths. To our knowledge, this is the ﬁrst
investigation of this kind to be performed. In addition to a
signiﬁcant reduction in seizure frequency and the mean duration
of seizures, the severity of seizures also decreased markedly. After
a dosage of 600 mg lacosamide, intense hypermotor seizures
stopped completely and only a few minor motoric events with
turning of the head persisted. This effect might be attributed
simply to the add-on of lacosamide because the dosage of OXC and
PGB were essentially constant during the observed time period.
Long-term monitoring results over several months, as well as
cognitive testing, were used to guide further stepwise dosage
decisions. In this case, in- and outpatient home-monitoring
therefore proved to be very helpful for guiding the treatment of
this severe epilepsy, which otherwise would be much more
difﬁcult to treat.
5. Conclusion
Wepresented data from two difﬁcult-to-treat epilepsy patients.
In one case, it was important to determine the actual seizure
frequency. In the other case, we sought to objectively quantify the
efﬁcacy of medication on a prolonged time scale. Both issues may
be sufﬁciently addressed only by using prolonged outpatient
video-EEG monitoring in combination with an efﬁcient and robust
automated seizure detection method. We are aware that only two
patients were investigated, and thus, our approach ismore or less a
feasibility study. In the future, more patients should be investi-
gated to demonstrate the usefulness of outpatient monitoring,
both in acute cases and prolongedmonitoring cases lasting several
months.
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